Premium
P4‐395: Inhibition of CYP2C9 by fluconazole reduces clearance and increases exposure to tarenflurbil
Author(s) -
Swabb Edward,
Harrison Shuree,
Woodland Deane,
Belcher Valerie,
Mather Gary
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.2465
Subject(s) - fluconazole , pharmacokinetics , tolerability , pharmacology , medicine , adverse effect , urinalysis , cyp2c9 , urine , cytochrome p450 , antifungal , metabolism , dermatology